These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6815696)

  • 1. Pharmaco-EEG study of 6-azamianserin (ORG 3770): dissociation of EEG and pharmacologic predictors of antidepressant activity.
    Fink M; Irwin P
    Psychopharmacology (Berl); 1982; 78(1):44-8. PubMed ID: 6815696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EEG, blood level, and behavioral effects of the antidepressant mianserin (ORG GB-94).
    Fink M; Irwin P; Gastpar M; DeRidder JJ
    Psychopharmacology (Berl); 1977 Nov; 54(3):249-54. PubMed ID: 413141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The psychopharmacological effects of repeated doses of fluvoxamine, mianserin and placebo in healthy human subjects.
    Curran HV; Lader M
    Eur J Clin Pharmacol; 1986; 29(5):601-7. PubMed ID: 3082644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic administration of the 6-aza analogue of mianserin (Org. 3770) and its enantiomers on behaviour and changes in noradrenaline metabolism of olfactory-bulbectomized rats in the "open field" apparatus.
    O'Connor WT; Leonard BE
    Neuropharmacology; 1986 Mar; 25(3):267-70. PubMed ID: 3703175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential therapeutic role of the enantiomers and metabolites of mianserin.
    Pinder RM; Van Delft AM
    Br J Clin Pharmacol; 1983; 15 Suppl 2(Suppl 2):269S-276S. PubMed ID: 6824558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular responses to mianserin hydrochloride: a comparison with tricyclic antidepressant drugs.
    Burgess CD; Turner P; Wadsworth J
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):21S-28S. PubMed ID: 341940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurochemical and electroencephalographical studies on the central actions of mianserin (author's transl)].
    Sakai Y; Matsui Y
    Nihon Yakurigaku Zasshi; 1980 Sep; 76(6):479-93. PubMed ID: 7203282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacology of mianserin, its main metabolites and 6-azamianserin.
    Nickolson VJ; Wieringa JH; van Delft AM
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Apr; 319(1):48-55. PubMed ID: 6287300
    [No Abstract]   [Full Text] [Related]  

  • 9. Differences in presynaptic alpha-blockade, noradrenaline uptake inhibition, and potential antidepressant activity between (+)- and (-)mianserin.
    Schoemaker H; Berendsen HH; Stevens HJ; Nickolson VJ
    Psychopharmacology (Berl); 1981; 74(2):137-42. PubMed ID: 6115445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mirtazapine increases cortical excitability in healthy controls and epilepsy patients with major depression.
    Münchau A; Langosch JM; Gerschlager W; Rothwell JC; Orth M; Trimble MR
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):527-33. PubMed ID: 15774440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of single doses of mianserin and amitriptyline on psychomotor tests in normal volunteers.
    Crome P; Newman B
    J Int Med Res; 1978; 6(6):430-4. PubMed ID: 363479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular effects of mianserin and amitriptyline in healthy volunteers.
    Wester HA; Siegers CP
    Int J Clin Pharmacol Ther Toxicol; 1980 Dec; 18(12):513-7. PubMed ID: 7228446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping.
    Saletu-Zyhlarz GM; Anderer P; Linzmayer L; Semlitsch HV; Assandri A; Prause W; Hassan Abu-Bakr M; Lindeck-Pozza E; Saletu B
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):199-215. PubMed ID: 12366873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mianserin: cardiovascular effects in elderly patients.
    Møller M; Thayssen P; Kragh-Sørensen P; Pedersen OL; Kristensen CB; Bjerre M; Benjaminsen S; Gram LF
    Psychopharmacology (Berl); 1983; 80(2):174-7. PubMed ID: 6410447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of mianserin--a comparative study with amitriptyline and a placebo in healthy subjects.
    Kopera H; Fluch N; Harpf H; Klein WW; Stulemeijer SM
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar; 18(3):104-9. PubMed ID: 7380584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurochemical and autonomic pharmacological profiles of the 6-aza-analogue of mianserin, Org 3770 and its enantiomers.
    de Boer TH; Maura G; Raiteri M; de Vos CJ; Wieringa J; Pinder RM
    Neuropharmacology; 1988 Apr; 27(4):399-408. PubMed ID: 3419539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mianserin: a decade of scientific development.
    Peet M; Behagel H
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):5S-9S. PubMed ID: 623702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic studies on mianserin and its interaction with clonidine.
    Elliott HL; McLean K; Sumner DJ; Reid JL
    Eur J Clin Pharmacol; 1981; 21(2):97-102. PubMed ID: 7341285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct enantiomeric separation of mianserin and 6-azamianserin derivatives using chiral stationary phases.
    Selditz U; Liao Y; Franke JP; de Zeeuw RA; Wikström H
    J Chromatogr A; 1998 Apr; 803(1-2):169-77. PubMed ID: 9634278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological aspects of mianserin.
    Pinder RM; van Delft AM
    Acta Psychiatr Scand Suppl; 1983; 302():59-71. PubMed ID: 6301219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.